Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Healthcare Biotechnology
Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Trillium Therapeutics Inc.
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Baylor1965on Dec 06, 2010 1:13pm
207 Views
Post# 17806725

RE: RE: RE: copy of my OSC emails re: sss.v

RE: RE: RE: copy of my OSC emails re: sss.v

Only an idiot would think that one moment that I’m a kid poster and the next I’m the CEO of SCT. LOL

 
If you are so sure that this is a pump and dump scam, then it is the doing of hedgefunds/investor groups/brokers etc and not the doing of SCT’s management. The CEO would be very interested in pursuing these allegations since it affects their reputation.

 

On the other hand, if you are still stating that the science of Stem Cell Therapeutics is a scam then they would be VERY interested in receiving a record of your emails to and from the OSA.

 

BTW how’s the weather in Ottawa?

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities